NCT02687828 - A Prospective, Mono-Country and Multi-center Study to Observe Safety and Effectiveness of Adalimumab in KoREan Intestinal Behcet's Disease(BD) Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 18, 2016

Primary Completion Date

March 30, 2020

Study Completion Date

March 30, 2020

Conditions

Intestinal Behcet's Disease (BD)

Trial Locations (10)

The Catholic Univ. of Korea /ID# 169245, Gyeonggi-do

Ajou University Hospital /ID# 147938, Suwon

Kyungpook National Univ Hosp /ID# 147937, Daegu

Kosin University Gospel Hosp /ID# 169244, Busan

Pusan Nat Univ Yangsan Hosp /ID# 169243, Yangsan

Yonsei University Health System, Severance Hospital /ID# 147932, Seodaemun-gu

Samsung Medical Center /ID# 147934, Seoul

Cath Univ Seoul St Mary's Hosp /ID# 147936, Seoul

Seoul National University Hospital /ID# 147933, Seoul

Asan Medical Center /ID# 147935, Seoul